{"id":"NCT01073865","sponsor":"AstraZeneca","briefTitle":"Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer","officialTitle":"An Open Label, Randomised, Parallel Group, Multicentre Study to Compare ZOLADEX™ 10.8 mg Given Every 12 Weeks With ZOLADEX 3.6 mg Given Every 4 Weeks in Pre-menopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02-26","primaryCompletion":"2012-09-19","completion":"2017-11-20","firstPosted":"2010-02-23","resultsPosted":"2014-01-10","lastUpdate":"2018-12-12"},"enrollment":222,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"ZD9393 (Zoladex) 10.8 mg","otherNames":["Zoladex"]},{"type":"DRUG","name":"ZD9393 (Zoladex) 3.6 mg","otherNames":["Zoladex"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to examine the efficacy and safety as well as the characteristics of the female hormone and study medications after administration in pre-menopausal women with estrogen receptor positive advanced breast cancer who were randomised in a 1:1 ratio to either of the two treatment groups; the ZD9393 3.6 mg depot group or ZD9393 10.8 mg depot group, both given in combination with tamoxifen tablets.","primaryOutcome":{"measure":"Number of Patients With Progression-free Survival (PFS) at 24 Weeks","timeFrame":"24 weeks after the first dosing","effectByArm":[{"arm":"Zoladex 10.8 mg","deltaMin":67,"sd":null},{"arm":"Zoladex 3.6 mg","deltaMin":68,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":55,"countries":["India","Japan","Philippines","South Korea","Taiwan","Thailand"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=637&filename=D8666C00001ClinicalStudyProtocol_personal_info_redacted_12December.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":108},"commonTop":["HOT FLUSH","NASOPHARYNGITIS","BACK PAIN","HEADACHE","NAUSEA"]}}